I migliori Ipi podcast (2024)

1
S11 Ep2: ASCO 2024 Plenary: NADINA Trial Neoadjuvant Ipi/Nivo vs Adjuvant Nivo for Resectable Stage III Melanoma 10:09

18d ago10:09

10:09

Drs Armstrong and Tawagi discuss the NADINA trial of neoadjuvant nivolumab/ipilimumab vs adjuvant nivolumab in resectable, macroscopic, stage III melanoma.Di OncLive® On Air

1
ASCO 2024 Plenary: NADINA Trial Neoadjuvant Ipi/Nivo vs Adjuvant Nivo for Resectable Stage III Melanoma 10:09

18d ago10:09

10:09

This week’s episode will be discussing updates from ASCO 2024 next with the practice changing NADINA trial presented on the Sunday of ASCO by Dr. Christian Blank during the plenary sessions: A multicenter, randomized, phase 3 trial comparing the efficacy of neoadjuvant ipilimumab plus nivolumab with standard adjuvant nivolumab in macroscopic resect…

1
Belarus: will the tide ever turn on Lukashenko and the regime’s repression? 23:48

22d ago23:48

23:48

On August 9, Belarus commemorates the sad anniversary of the 2020 presidential elections, which resulted in the fraudulent reelection of Belarusian leader Alexander Lukashenko. In the aftermath of the elections, Belarus experienced unprecedented levels of repression at the hands of the Lukashenko regime’s security services, with part of this violen…

1
Post Podcast: IPI Financial Services shares Medicare updates 14:15

22d ago14:15

14:15

On this episode of the Post Podcast, IPI Financial Services account executive Gene Stramel discusses Medicare updates with Hays Post reporter Becky Kiser.Di Hays Post

1
S11 Ep7: Chiang Contextualizes the Optimal Use of Lurbinectedin in SCLC Management 8:44

1d ago8:44

8:44

Dr Chiang discusses the use of lurbinectedin in small cell lung cancer and tips for managing toxicities associated with this agent.Di OncLive® On Air

1
Palliative Care x Dr. Janet Abrahm Part 1 27:44

3d ago27:44

27:44

In Part 1 we discuss how to explain palliative care to patients, pain and anti-emetic management, non-pharmacologic strategies, and current innovations within palliative care. We are so honored to have Dr. Janet Abrahm here with us who is a national leader in the field of palliative care and a professor at Harvard Medical School.…

1
Hays Chamber, DSNWK discuss workforce development 11:49

4d ago11:49

11:49

On this episode of The Post Podcast Hays Post reporter Becky Kiser discusses workforce development with The Chamber in Hays, Kansas president and CEO Sarah Wasinger and DSNWK employment services manager LaVonne Giess.Di Hays Post

1
S11 Ep6: FDA Approval Insights: Dostarlimab Plus Chemotherapy in Advanced/Recurrent Endometrial Cancer 8:37

4d ago8:37

8:37

Dr Tewari discusses the FDA approval of dostarlimab plus chemotherapy for patients with primary advanced or recurrent endometrial cancer.Di OncLive® On Air

1
New Hays housing, business developments okayed for economic development incentives 13:40

6d ago13:40

13:40

On this episode of The Post Podcast Hays Post reporter Becky Kiser speaks with vice mayor Sandy Jacobs and deputy city manager Collin Bielser about project developments in HaysDi Hays Post

1
🎤Heartland Community Foundation welcomes new Trego County Development Director 10:32

8d ago10:32

10:32

On this episode of the Post Podcast, Hays Post reporter Becky Kiser speaks with Heartland Community Foundation Executive Director Sarah Meitner and Savannah Downing, about her new role as the new Trego County Development Director. Read more at Hays Post.Di Hays Post

1
S11 Ep5: Jhaveri on the INAVO120 Trial of Inavolisib/Palbociclib/Fulvestrant in PIK3CA -Mutant, HR+ Breast Cancer 9:17

8d ago9:17

9:17

Dr Jhaveri discusses the INAVO120 trial of inavolisib plus palbociclib and fulvestrant in PIK3CA-mutant, HR-positive metastatic breast cancer.Di OncLive® On Air

1
S11 Ep4: Park and Kasi Expand on Perioperative Immunotherapy Updates in CRC 10:46

9d ago10:46

10:46

Drs Park and Kasi delve into the shift toward neoadjuvant immunotherapy and the use of ctDNA as a prognostic tool in colorectal cancer.Di OncLive® On Air

1
S11 Ep3: Garcia-Manero on MDS Treatment Updates With Luspatercept and Beyond 15:00

11d ago15:00

15:00

Dr Garcia-Manero discusses findings from research in myelodysplastic syndromes that were presented at the 2024 EHA Congress.Di OncLive® On Air

1
Hemophilia 2024 UPDATE 16:22

12d ago16:22

16:22

This week’s episode will be repeating our episode on hemophilias with some updates. We will go over all high yield facts regarding both hemophilia A and B for your boards and end with a little bit about acquired hemophilias.

1
As Hays city leaders discuss expansion, Grow Hays director explains the role incentive districts 15:05

14d ago15:05

15:05

On this episode of the Post Podcast, Hays Post Reporter Cristina Janney speaks with Grow Hays Executive Director Doug Williams about incentive districts as Hays city leaders are looking for expansion opportunities. Read more at Hays Post.Di Hays Post

1
S11 Ep3: FDA Approval Insights: Durvalumab/Chemotherapy in dMMR Advanced Endometrial Cancer 9:25

15d ago9:25

9:25

Dr Westin discusses the FDA approval of durvalumab plus chemotherapy for patients with dMMR advanced or recurrent endometrial cancer.Di OncLive® On Air

1
S11 Ep1: Rotow Reviews Key Updates on the Management of CNS Metastases in NSCLC 10:13

22d ago10:13

10:13

Dr Rotow discusses data that demonstrated the central nervous system activity of datopotamab deruxtecan and osimertinib in patients with NSCLC.Di OncLive® On Air

1
41st-annual Herzogfest opens Friday in Victoria 8:01

23d ago8:01

8:01

On this episode of the Post Podcast Hays Post reporter Becky Kiser speaks with Herzogfest president Brenton Hoffman about the upcoming event. Read more at Hays Post.Di Hays Post

1
Grow Hays director discusses latest development north of I-70 14:41

23d ago14:41

14:41

On this episode of the Post Podcast, Hays Post Reporter Cristina Janney speaks with Grow Hays Executive Director Doug Williams about development north of I-70, near Home Depot.Di Hays Post

1
S10 Ep50: Park and Grivas Expand on Treatment Updates in Bladder Cancer 16:13

23d ago16:13

16:13

Drs Park and Grivas discuss bladder cancer treatment updates, including results from the SunRISe-1 trial of TAR-200 plus cetrelimab in NMIBC.Di OncLive® On Air

1
Downtown Hays Farmers Market voted No. 1 in Kansas for 2nd year 10:14

24d ago10:14

10:14

On this episode of the Post Podcast, Hays Post reporter Becky Kiser speaks with Downtown Development Corp. executive director Julie Rider about the Downtown Hays Farmers Market, voted No. 1 in Kansas for the second year. Read more on Hays Post.Di Hays Post

1
Ellis Co. officials discuss changes to emergency communications 10:50

24d ago10:50

10:50

On this episode of the Post Podcast Hays Post reporter Cristina Janney discusses changes to the emergency communications across Ellis County with County Administrator Darin Myers and Communications Director Jeff Ridgway. Read more about recent changes on Hays Post.Di Hays Post

1
S10 Ep49: Halmos on the AE Profiles of Dato-DXd and Other ADCs in NSCLC 10:02

25d ago10:02

10:02

Dr Halmos discusses common AEs associated with the ADCs that are used in NSCLC and ways to manage and mitigate these toxicities.Di OncLive® On Air

1
Oncology for the IM Board Tips 2024 14:47

26d ago14:47

14:47

Today’s episode is a continuation on fast facts for the IM Board review focusing on the oncology questions. Another 6% of the certifying ABIM test is oncology. While we can’t cover ALL of oncology in just 10 minutes, here are 10 high yield concepts/facts/vignettes you should know walking into your IM Boards.…

1
S10 Ep48: Lisberg Lends Insight About the TROPION-Lung01 Trial of Dato-DXd in NSCLC 12:49

29d ago12:49

12:49

Dr Lisberg discusses key findings from the TROPION-Lung01 trial of Dato-DXd in patients with previously treated advanced or metastatic NSCLC.Di OncLive® On Air

1
Hematology for the IM Board Tips 2024 16:49

1M ago16:49

16:49

Today’s episode focuses on what you need to know to ace the hematology questions for your 2024 IM boards. 6% of the ABIM exam is hematology which includes erythrocyte, leukocyte and platelet disorders, coagulation disorders, transfusion medicine, and heme malignancies. We discuss some common vignettes & high yield points.…

1
S10 Ep47: Pegram Details the Use of Oral SERDs in ESR1+ Metastatic Breast Cancer 11:09

1M ago11:09

11:09

Di OncLive® On Air

1
S10 Ep47: Miller Discusses the Use of Selinexor in TP53 Wild-Type Advanced Endometrial Cancer 11:09

1M ago11:09

11:09

Dr Miller discusses findings from the SIENDO trial of selinexor maintenance therapy in patients with TP53 wild-type advanced endometrial cancer.Di OncLive® On Air

1
Victoria, rural Ellis County voters to decide on county library monies 13:47

1M ago13:47

13:47

On this episode of the Post Podcast Hays Post reporter Jonathan Zweygardt discusses Ellis County Library funds with County Administrator Darin Myers and Commissioner Michael Berges. Read more at Hays Post.Di Hays Post

1
S10 Ep46: Park and Sonpavde on Sacituzumab Govitecan Plus Enfortumab Vedotin in Metastatic Urothelial Cancer 22:17

1M ago22:17

22:17

Drs Park and Sonpavde discuss findings from the phase 1 DAD trial, as well as a schema for the frontline management of metastatic urothelial carcinoma.Di OncLive® On Air

1
Seniors help seniors as FHSU companion program celebrates 50 years 5:43

1M ago5:43

5:43

On this episode of the Post Podcast, Hays Post reporter Cristina Janney speaks with Tawnya Rohr, Senior Companion Program director, about their 50-year anniversary. Read more at Hays Post.Di Hays Post

1
Infusion Reactions 12:34

1M ago12:34

12:34

This week’s episode will be focusing on infusion reactions - one of the most common calls we get as heme/onc fellows and high yield facts for new fellows as well as boards. We will go over the important details on mechanisms of infusion reaction, class of drugs that most commonly cause infusion reactions, treatment for infusion reactions, and when/…

1
Grow Hays director discusses incentive district for The Grove 11:26

1M ago11:26

11:26

On this episode of the Post Podcast, Hays Post Reporter Cristina Janney speaks with Grow Hays Executive Director Doug Williams about development projects in Hays. Read more on Hays Post.Di Hays Post

1
S10 Ep45: Bui and Kelly Discuss the Utility of Nab-Sirolimus in Advanced Malignant PEComa 17:30

1M ago17:30

17:30

Drs Bui and Kelly discuss key long-term findings from the AMPECT trial investigating nab-sirolimus in patients with advanced malignant PEComa.Di OncLive® On Air

1
Press freedom in peril: navigating elections and political turmoil in Poland, Slovakia and Bulgaria 42:26

1M ago42:26

42:26

As politics in Eastern Europe becomes increasingly volatile during the super election year, press freedom is at grave risk. Throughout the pre- and post-election periods, independent media face numerous threats, including verbal and physical assaults, cyber attacks, smear campaigns, and vexatious lawsuits. As the dust settles on the European Parlia…

1
S10 Ep44: Curigliano on the DESTINY-Breast06 Trial in HER2-Low and -Ultralow Metastatic Breast Cancer 10:35

2M ago10:35

10:35

Dr Curigliano discusses the DESTINY-Breast06 trial of trastuzumab deruxtecan in patients with HER2-low or HER2-ultralow metastatic breast cancer.Di OncLive® On Air

1
Oncologic Emergencies 12:27

2M ago12:27

12:27

This week’s episode will be focusing on common topics both for new fellows & residents. We will go over the important details on some clinically important oncologic emergencies including brain metastases, hypercalcemia, cord compression and SVC syndrome.

1
Cottonwood Extension District shares tractor safety information 11:53

2M ago11:53

11:53

On this episode of the Post Podcast, Hays Post reporter Becky Kiser discusses tractor safety with Cottonwood Extension District with agent Stacy Campbell.Di Hays Post

1
S10 Ep43: Orlowski on Isa-VRd in Transplant-Ineligible Multiple Myeloma 10:05

2M ago10:05

10:05

Dr Orlowski discusses key efficacy data from the IMROZ trial of Isa-VRd in newly diagnosed, transplant-ineligible multiple myeloma.Di OncLive® On Air

1
S10 Ep42: Park and Sonpavde on Nivolumab Plus Gemcitabine/Cisplatin in Cisplatin-Eligible Urothelial Cancer 7:31

2M ago7:31

7:31

Drs Park and Sonpavde discuss the CheckMate901 trial, which showed survival improvements with nivolumab plus chemotherapy in metastatic urothelial cancer.Di OncLive® On Air

1
S10 Ep41: ASCO 2024 Plenary: ADRIATIC Trial in Limited-Stage Small Cell Lung Cancer 12:26

2M ago12:26

12:26

OncLive On Air partners with Two Onc Docs to bring insights on the ADRIATIC trial, data from which were presented at the 2024 ASCO Annual Meeting.Di OncLive® On Air

1
ASCO 2024 Plenary: ADRIATIC Trial in Limited Stage Small Cell Lung Cancer 12:26

2M ago12:26

12:26

This week’s episode will discuss updates from ASCO 2024 next with the practice changing ADRIATIC trial presented by Dr. Spigel during the plenary: Durvalumab as consolidation treatment for patients with limited-stage small-cell lung cancer (LS-SCLC).

1
S10 Ep40: FDA Approval Insights: Imetelstat in Lower-Risk MDS and Transfusion-Dependent Anemia 7:48

2M ago7:48

7:48

Dr Sekeres discusses the significance of the FDA approval of imetelstat for patients with lower-risk MDS and transfusion-dependent anemia.Di OncLive® On Air

1
Tips for New Doctors (& A Few For New Attendings) 27:48

2M ago27:48

27:48

In light of the new academic year today, we are so excited for this special episode, hosting Dr Shikha Jain, who is the founder of Women in Medicine & a GI oncologist, & involved with ASCO Women's Networking Center. She shares some of her tips for new doctors, and a few for new attendings.

1
S10 Ep39: Dietrich and Shiller Dive Into the Importance of Oncology Reflex Testing 18:32

2M ago18:32

18:32

Drs Dietrich and Shiller detail the importance of collaboration between medical oncologists and pathologists to ensure beneficial oncology reflex testing.Di OncLive® On Air

1
Ellis County Historical Society director shares updates 12:00

2M ago12:00

12:00

On this episode of The Post Podcast, Hays Post reporter Jonathan Zwedgardt speaks with Ellis County Historical Society director Amanda Rupp about summer activities and recent developments.Di Hays Post

1
EMS: Take cautions during hot temperatures; stay hydrated 10:04

2M ago10:04

10:04

On this episode of the Post Podcast, Matt Meagher, assistant director of Ellis County Emergency Medical Services, cautions residents to be aware of the sun and the heat index, whether outdoors or indoors, with Hays Post reporter Becky Kiser. Read more at Hays Post.Di Hays Post

1
S10 Ep38: Agulnik Highlights Key Updates in GIST Research and Management 16:25

2M ago16:25

16:25

Dr Agulnik spotlights key updates from across the GIST landscape ahead of GIST Awareness Day on July 13.Di OncLive® On Air

1
Acute Myeloid Leukemia (AML) 2024 x Dr. Catherine Lai Part 2 17:29

2M ago17:29

17:29

Today’s episode is an update on AML (acute myeloid leukemia). In Part 2 we discuss the treatment options for first-line, as well as relapsed/refractory disease. We are so honored to have Dr. Catherine Lai here with us who is Associate Professor and Physician Leader of the Leukemia Clinical Research Unit at UPenn.…

1
S10 Ep37: Reckamp Discusses the Integration of Pragmatic Elements Into Oncology Clinical Trial Designs 9:57

2M ago9:57

9:57

Dr Reckamp discusses the definition of pragmatic clinical trials and ways that clinical trial investigators can make their research more pragmatic.Di OncLive® On Air

Podcast che vale la pena ascoltare

Podcast di Ipi

Podcast che vale la pena ascoltare

Guida rapida